A detailed history of Creative Planning transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Creative Planning holds 55,351 shares of BHC stock, worth $409,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,351
Previous 47,356 16.88%
Holding current value
$409,043
Previous $330,000 36.67%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$5.22 - $8.26 $41,733 - $66,038
7,995 Added 16.88%
55,351 $451,000
Q2 2024

Aug 15, 2024

SELL
$6.1 - $10.41 $1,866 - $3,185
-306 Reduced 0.64%
47,356 $330,000
Q1 2024

May 10, 2024

SELL
$7.77 - $10.61 $1,235 - $1,686
-159 Reduced 0.33%
47,662 $505,000
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $87,123 - $109,804
-13,342 Reduced 21.81%
47,821 $383,000
Q3 2023

Nov 16, 2023

SELL
$7.69 - $9.71 $60,158 - $75,961
-7,823 Reduced 11.34%
61,163 $502,000
Q2 2023

Jul 21, 2023

SELL
$5.72 - $8.8 $554 - $853
-97 Reduced 0.14%
68,986 $551,000
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $9,463 - $14,843
1,507 Added 2.23%
69,083 $559,000
Q4 2022

Feb 10, 2023

BUY
$6.09 - $7.93 $17,551 - $22,854
2,882 Added 4.45%
67,576 $424,000
Q3 2022

Nov 03, 2022

BUY
$4.58 - $9.21 $167,376 - $336,579
36,545 Added 129.83%
64,694 $446,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $13,555 - $45,369
-1,920 Reduced 6.39%
28,149 $235,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $470,080 - $604,793
-21,763 Reduced 41.99%
30,069 $687,000
Q4 2021

Feb 11, 2022

SELL
$23.0 - $29.01 $39,836 - $50,245
-1,732 Reduced 3.23%
51,832 $1.43 Million
Q3 2021

Nov 10, 2021

SELL
$25.04 - $30.06 $645,756 - $775,217
-25,789 Reduced 32.5%
53,564 $1.49 Million
Q2 2021

Aug 04, 2021

SELL
$27.43 - $32.7 $1.63 Million - $1.94 Million
-59,333 Reduced 42.78%
79,353 $2.33 Million
Q1 2021

Apr 30, 2021

SELL
$21.37 - $34.38 $109,585 - $176,300
-5,128 Reduced 3.57%
138,686 $4.4 Million
Q4 2020

Jan 29, 2021

SELL
$15.31 - $21.12 $560,101 - $772,654
-36,584 Reduced 20.28%
143,814 $2.99 Million
Q3 2020

Nov 05, 2020

BUY
$14.88 - $20.13 $1.26 Million - $1.7 Million
84,382 Added 87.88%
180,398 $2.8 Million
Q2 2020

Jul 23, 2020

BUY
$13.31 - $20.51 $4,032 - $6,214
303 Added 0.32%
96,016 $1.76 Million
Q1 2020

May 05, 2020

SELL
$12.98 - $30.25 $519,238 - $1.21 Million
-40,003 Reduced 29.48%
95,713 $1.48 Million
Q4 2019

Jan 30, 2020

SELL
$18.89 - $31.89 $660,054 - $1.11 Million
-34,942 Reduced 20.47%
135,716 $4.06 Million
Q3 2019

Nov 01, 2019

BUY
$20.88 - $25.66 $206,879 - $254,239
9,908 Added 6.16%
170,658 $3.73 Million
Q2 2019

Jul 26, 2019

SELL
$20.52 - $26.45 $1.2 Million - $1.55 Million
-58,587 Reduced 26.71%
160,750 $4.05 Million
Q1 2019

Apr 24, 2019

BUY
$20.23 - $26.29 $840,677 - $1.09 Million
41,556 Added 23.37%
219,337 $5.42 Million
Q4 2018

Feb 01, 2019

SELL
$17.64 - $28.32 $1.57 Million - $2.51 Million
-88,785 Reduced 33.31%
177,781 $3.28 Million
Q3 2018

Oct 25, 2018

BUY
$20.64 - $25.67 $5.5 Million - $6.84 Million
266,566 New
266,566 $6.84 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.